Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	719	375	360	587	402	441
Market Cap Growth	28.86%	3.96%	-38.56%	46.02%	-8.90%	-37.30%
Enterprise Value	469	309	276	501	261	415
PE Ratio	-	-2.12	-3.54	-6.68	-6.86	3.39
PS Ratio	311.28	311.24	2593.28	1968.62	16.74	1.37
PB Ratio	2.49	4.03	3.08	5.16	2.57	3.77
P/FCF Ratio	-3.18	-2.31	-4.00	-6.65	-3.04	3.88
P/OCF Ratio	-3.19	-2.31	-4.06	-6.74	-2.81	3.88
EV/Sales Ratio	202.82	257.04	1986.42	1681.53	10.88	1.29
EV/EBITDA Ratio	-1.93	-1.89	-2.80	-5.78	-6.35	2.79
EV/EBIT Ratio	-1.92	-1.89	-2.78	-5.76	-5.93	2.86
EV/FCF Ratio	-1.83	-1.91	-3.06	-5.68	-1.98	3.64
Debt / Equity Ratio	0.36	1.13	0.46	0.01	0.07	2.09
Debt / EBITDA Ratio	-0.59	-0.64	-0.55	-0.01	-0.28	1.65
Debt / FCF Ratio	-0.57	-0.65	-0.60	-0.01	-0.09	2.16
Quick Ratio	15.26	5.42	5.97	3.92	3.26	5.02
Current Ratio	15.58	5.60	6.08	4.02	3.37	5.17
Asset Turnover	0.01	0.01	0.00	0.00	0.09	0.95
Interest Coverage	-10.93	-12.52	-35.67	-108.42	-3.03	7.00
Return on Equity (ROE)	-109.40%	-139.70%	-96.00%	-65.00%	-81.30%	304.00%
Return on Assets (ROA)	-62.50%	-71.90%	-64.30%	-52.10%	-21.80%	38.40%
Return on Capital (ROIC)	-47.21%	-86.79%	-58.88%	-75.87%	-28.45%	40.93%
Earnings Yield	-26.91%	-47.27%	-28.28%	-14.96%	-14.58%	29.51%
FCF Yield	-25.81%	-43.33%	-25.02%	-15.04%	-32.87%	25.79%
Buyback Yield / Dilution	-29.83%	-33.43%	-13.79%	-31.41%	5.06%	-10.32%
Total Shareholder Return	-29.83%	-33.43%	-13.79%	-31.41%	5.06%	-10.32%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).